Skip to main content

Table 4 Follow-up of 21 patients assessed for chest pain with an initial hs-cTnT level of ≥15 ng/L but no signs of AMI or UA

From: Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study

  hs-cTnT ≥15 ng/L without AMI or UA n = 21 hs-cTnT after 2–3 years P value
<15 ng/L n = 7 ≥15 ng/L n = 14
Age (years) 81 ± 9 75 ± 9 83 ± 7 0.049
Male 16 (76) 5 (71) 11 (79) 1.000
Risk factors
 Current smokers 0 0 0  
 Diabetes 6 (29) 2 (29) 4 (29) 1.000
 Hypertension 18 (86) 5 (71) 13 (93) 0.247
 Hypercholesterolaemia 7 (33) 3 (43) 4 (29) 0.638
Cardiovascular disease
 Angina pectoris 1 (5) 1 (14) 0 0.333
 Previous AMI 3 (14) 2 (29) 1 (7) 0.247
 Heart failure 3 (14) 1(14) 2 (14) 1.000
 Aortic valve disease 3 (14) 1 (14) 2 (14) 1.000
ECG findings
 Atrial fibrillation 8 (38) 2 (29) 6 (43) 0.656
Laboratory findings     
 eGFR (mL/min) 62 ± 17 74 ± 11 56 ± 16 0.017
 NT-proBNP (ng/L)a 440 ± 775 150 ± 338 1,245 ± 883 0.017
 Cholesterol (mmol/L) 4.5 ± 1.3 4.4 ± 1.7 4.6 ± 1.2 0.754
Symptoms and findings
 Angina pectoris or dyspnoea 3 (14) 2 (29) 1 (7) 0.247
 Length (cm) 173 ± 7 173 ± 10 173 ± 7 0.847
 Body weight (kg) 85 ± 13 85 ± 10 84 ± 15 0.889
 BMI (kg/m2) 28 ± 4 29 ± 5 28 ± 4 0.862
 Waist circumference (cm) 106 ± 11 107 ± 11 106 ± 11 0.878
 Systolic BP (mm Hg)a 120 ± 10 120 ± 2.5 130 ± 11 0.176
 Diastolic BP (mm Hg)a 70 ± 6 70 ± 7 65 ± 6 0.658
  1. Patients are divided into groups according to hs-cTnT level 2–3 years after the initial assessment.
  2. Values are presented as mean ± SD or number (%) as appropriate.
  3. aMedian ± quartile deviation.